NEW YORK, Feb. 4, 2023 (GLOBE NEWSWIRE) —

Atlas Technical Advisors, Inc. ATCX

Lifshitz Law PLLC Announces an investigation into a possible breach of fiduciary duties in connection with the sale of ATCX to GI Partners for $12.25 per share in cash.

If you are an ATCX investor and would like additional information about our research, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@lifshitzlaw.com.

Chembio Diagnostics, Inc. CEMI

Lifshitz Law PLLC Announces an investigation into a possible breach of fiduciary duties in connection with the sale of CEMI to Biosynex SA for $0.45 per share.

If you are a CEMI investor and would like additional information about our investigation, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@lifshitzlaw.com.

Leap Therapeutics, Inc. LPTX

Lifschitz LAwPLC announces an investigation into a possible breach of fiduciary duties in connection with the merger of LPTX and Flame Biosciences, Inc., whereby LPTX will issue approximately 19,794,373 shares of its common stock and approximately 136,833 shares of a newly designated Series X non-voting convertible preferred stock to Flame shareholders.

If you are an LPTX investor and would like more information about our research, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@lifshitzlaw.com.

Evoqua Water Technologies Corp. AQUA

Lifshitz Law PLLC announces an investigation into a possible breach of fiduciary duties in connection with the sale of AQUA to Xylem Inc. for 0.480 Xylem shares for each AQUA share held.

If you are an AQUA investor and would like additional information about our research, please fill out Information Request Form or contact Joshua Lifshitz, Esq. by phone at (516) 493-9780 or by email info@lifshitzlaw.com.

LAWYER…